Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio— 510(k) K242706

Substantially Equivalent

Fujirebio Diagnostics,Inc.

FDA 510(k) clearance K242706 for Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, Substantially Equivalent on 2025-05-16. Applicant: Fujirebio Diagnostics,Inc.. Device class: 2.

Clearance details

Applicant
Fujirebio Diagnostics,Inc.
Product code
Code SET
Device class
Class 2
Regulation
21 CFR 866.5840
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Malvern, PA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code SET

view all

More clearances from Fujirebio Diagnostics,Inc.

view all

Recalls naming K242706

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K242706.

Data sourced from openFDA. This site is unofficial and independent of the FDA.